Document is current
Any future updates will be listed below
-
Authors
Kodali, Srikanth http://orcid.org/0000-0001-9330-9880
Proietti, Ludovica http://orcid.org/0000-0002-3077-0079
Valcarcel, Gemma http://orcid.org/0000-0003-0494-9128
López-Rubio, Anna V. http://orcid.org/0000-0001-8664-6205
Pessina, Patrizia http://orcid.org/0000-0002-4227-411X
Eder, Thomas http://orcid.org/0000-0002-0932-2052
Shi, Junchao http://orcid.org/0000-0002-1548-5069
Jen, Annie http://orcid.org/0000-0001-5569-8387
Lupión-Garcia, Núria http://orcid.org/0000-0001-6493-9293
Starner, Anne C.
Bartels, Mason D.
Cui, Yingzhi http://orcid.org/0009-0005-8475-3361
Sands, Caroline M. http://orcid.org/0000-0002-3232-7716
Planas-Riverola, Ainoa
Martínez, Alba http://orcid.org/0000-0001-7514-260X
Velasco-Hernandez, Talia http://orcid.org/0000-0003-2183-7443
Tomás-Daza, Laureano http://orcid.org/0000-0002-6127-1694
Alber, Bernhard http://orcid.org/0000-0002-7601-4826
Manhart, Gabriele
Mayer, Isabella Maria http://orcid.org/0000-0002-9164-9547
Kollmann, Karoline http://orcid.org/0000-0002-7937-4245
Fatica, Alessandro http://orcid.org/0000-0002-0743-7905
Menendez, Pablo
Shishkova, Evgenia
Rau, Rachel E.
Javierre, Biola M. http://orcid.org/0000-0002-8682-6748
Coon, Joshua http://orcid.org/0000-0002-0004-8253
Chen, Qi http://orcid.org/0000-0001-6353-9589
Van Nostrand, Eric L. http://orcid.org/0000-0002-5188-0082
Sardina, Jose L. http://orcid.org/0000-0002-8493-3937
Grebien, Florian http://orcid.org/0000-0003-4289-2281
Di Stefano, Bruno http://orcid.org/0000-0003-2532-3087
-
Funding
Funding for this research was provided by:
Cancer Prevention and Research Institute of Texas (RR200079, RR200040)
American Society of Hematology
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (1R35GM147126-01, 1F32CA288043-01, 5T32DK060445-19)
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (CP22/00127, CP19/00176)
Worldwide Cancer Research (20-0269)
Austrian Science Fund (P-35628, P35298)
- License Information
-
More Information
Article History
Received: 18 September 2023
Accepted: 18 July 2024
First Online: 21 August 2024
Competing interests
: E.V.N. is co-founder, member of the Board of Directors, on the SAB, equity holder and paid consultant for Eclipse BioInnovations, on the SAB of RNAConnect and is inventor of intellectual property owned by University of California San Diego. The interests of E.V.N. have been reviewed and approved by the Baylor College of Medicine in accordance with its conflict of interest policies. P.M. is a co-founder, member of the Board of Directors, equity holder and paid consultant for OneChain Immunotherapeutics (Barcelona, Spain). This work has no connection with and is not related to the scientific interests of OneChain Immunotherapeutics. J.J.C. is a consultant for Thermo Fisher Scientific, 908 Devices and Seer. The remaining authors declare no competing interests.
